Form 4 for VRCA Verrica Pharmaceuticals Inc.
Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-06 · accession 0001415889-24-026290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-06 | 2024-11-06 | VRCA | Kirby John J. | Interim CFO | A - Grant | $0.00 | +54.3K | 54.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | A | A | 54,267 | $0.00 | 54,267 | D | — | — | (F1) Represents a restricted stock unit ("RSU") award. The RSUs shall vest vest in full on May 4, 2025, subject to the Reporting Person's continuous service through such date. |